CSI Market
Sign In | Register

60 Degrees Pharmaceuticals Inc (SXTP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SXTP Annual Cash Flow →
This page allows investors to follow 60 Degrees Pharmaceuticals Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-8.96
Depreciation & amortization0.03
Amortization of Other Assets0.02
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-0.26
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation0.35
Income (Loss) from Equity Method Investments0.00
Adjustment of Warrants Granted for Services0.01
Finance Lease Right Of Use Asset Amortization-
Fair Value Option Changes In Fair Value Gain Loss-
Amortization Of Debt Discount-
Amortization Of Note Issuance Costs-
Amortization Of Capitalized Share Based Payments0.04
Derivative Gain Loss On Derivative Net0.00
Gain Loss On Derivative Instruments Net Pretax-
Cost Of Goods And Services Sold Amortization-
Capitalized Contract Cost Amortization-
Share Based Compensation Under Equity Incentive Plan-
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.05
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.25
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.38
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.65
Discontinued operations0.00
Net Cash flow from Operating Activities-4.97
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Short-term Investments1.24
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.03
Discontinued operations0.00
Net Cash Flow from Investing Activities1.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net3.37
Net Proceeds From Shares And Warrants Offering-
Proceeds From Issuance A T M Offering Costs3.37
Proceeds From Exercise Of Pre Funded Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.37
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-5.07
Total Cash Flow-0.49
4 historic quarters locked

Sign in to unlock the full 60 Degrees Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About 60 Degrees Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001554855-26-001860

Figures are derived from filed reports and may be restated. Historical data is subject to revision.